ADREVIEW Iobenguane (I-123) sol inj 37 MBq
7680525380257
CH-52538
V09IX01
17.01.9.
1 / 3
google
Details
- Product number
- 5253801
- CPT
- -
- Packaging group
- 37
- Unit
- MBq
- Composition
- iobenguanum (I-123) zum Kalibrierungszeitpunkt 74 MBq, iobenguani hydrogenosulfas(127-I), cupri phosphas, natrii hydroxidum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, alcohol benzylicus 10.3 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.23 mg.
Articles (1)
AdreView, Iobenguane (I-123) Injection
Iobenguane (I-123) Injection
37
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
74.0 MBQ | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
10.3 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
4.23 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 335.30
Specialties list
Yes
Generic
No
SL addition date:
01/06/1999
Authorization holder
medeo AG
5405 Baden
Authorization information
- Swissmedic authorization number
- 52538
- Drug name
- AdreView, Injektionslösung (I-123), Injection
- Galenic form
- LSPA
- ATC Code
- V09IX01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/12/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 17.01.9.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ADREVIEW Iobenguane (I-123) sol inj 37 MBq
- Description (DE)
- ADREVIEW Iobenguane (I-123) Inj Lös 37 MBq
- Market launch
- 29/12/1994
- Narcotic (BTM)
- No